LDL-Cholesterin-Senkung - Kann die Lipidtherapie den Katheter ersetzen? • diabetologie-online
Lipidtherapie bei Diabetes – Warum ein LDL-Cholesterin von < 70 mg/dl? | Diabetes Forum
PDF] How to reach LDL targets quickly in patients with diabetes or metabolic syndrome. | Semantic Scholar
What is the optimal medical approach to managing dyslipidemia in type 2 diabetes? | Consultant360
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study - ScienceDirect
FIGURE 9.42, Mean LDL Cholesterol Among Adults Age ≥20 Years, by Diabetes Status and Lipid-Lowering Medication, U.S., 2005–2010 - Diabetes in America - NCBI Bookshelf
Fortbildung - Diabetes und Fettstoffwechselstörungen • diabetologie-online
Kardiovaskulären Risikoprofil entscheidend für frühzeitige Therapie - LDL -senken
Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl | PLOS ONE
Fette – Praxis Dr. med. Katrin Stephan
Intensive lipid-lowering therapy in high-risk diabetic patients | Hypertension Research
AACE Endorses New Lower LDL Targets and ApoB Testing
Diabetes and Lipid Management - Endocrinology Advisor
Diagnose und Therapie der Hypertriglyceridämie
Treating Dyslipidemia: Recommendations for Type 2 Diabetics | Consultant360
Target lipoprotein levels for patients with diabetes | Download Table
Fettstoffwechselstörung und Arteriosklerose - diabetes-news : diabetes-news
Treating Hyperglycemia and Dyslipidemia in People With Diabetes: Achieving Optimal Treatment Targets
Lipidtherapie bei Diabetes – Warum ein LDL-Cholesterin von < 70 mg/dl? | Diabetes Forum